Analysis News

  • The best newsletter in the market
  • Customisable and personal
  • By e-mail every morning, for free

Receive Analysis News:

E-mail:

Free daily newsletter every morning

Content
Signaux
Tous les indices - Moyen terme
AstraZeneca18. oct 2019
G4S18. oct 2019
Avast PLC18. oct 2019
Fevertree Drinks Plc18. oct 2019
BBA Aviation PLC18. oct 2019

The market showed a small loss vendredi, and FTSE 100 (UKX) ended the day at 7151 points, which is a decline of 0.44 percent. For the week as a whole the index showed a loss of 1.3%.

759 shares showed a gain and 997 showed a loss. 163 shares were unchanged and closed at the same price as the previous day. There was no trading in 415 shares.

Total value of the trading volume for shares and primary capital certificates vendredi was approximately 530.3 billion.

Royal Dutch Shell PLC (RDSB) was down 0.87 percent to close at 2227 pence. L'action thereby broke the earlier bottom it set janvier 28 and reached a new year-low. L'action has thereby closed down eight out of the past nine days. It does not look good technically either. L'action is trend wise negative in the medium term, has marginally broken down through the support at 2230 pence and a further decline is indicated.
Experian PLC (EXPN) lost 1.33 percent to 2371 pence. L'action has now closed down for the eighth day in a row. L'action has by that dropped 2.91 percent since the sell signal from formation double sommet three days ago.
Rolls-Royce Holdings PLC (RR) lost 2.47 percent to 712 pence. L'action has not closed at a lower price since février 2017. L'action has now closed down for the fourth day in a row and this past month l'action has lost as much as 11.38 percent. Nor technically does it look good. L'action is trend wise negative in the medium term and a further decline is indicated.
InterContinental Hotels Group (IHG) closed at 4520 pence after posting a loss of 4.58 percent. L'action has never lost more in one day since juillet 25. 2018, when it was down 4.83 percent. It does not look good technically either. L'action has broken down through the support at 4620 pence.
Dart Group (DTG) ended with a solid gain of 5.73 percent and closed at 1236 pence. L'action has now closed up for the fourth day in a row and this past month l'action has gained as much as 55.86 percent. The volume was also high. At session end it was bought and sold shares for about 4828 million pence in l'action, which equals six times mean daily turnover. Technically it also looks good. L'action is trend wise positive in the medium term and a further increase is indicated.

US 500 weakly lower vendredi
The market showed a small loss vendredi, and S&P 500 (SP500) ended the day at 2986 points, which is a decline of 0.39 percent. The week as a whole showed a gain of 0.5%.

Indices
FTSE 100
   A surveiller
FTSE 100 a débordé du canal haussier à la baisse. Cela indique dans un premier temps, un taux de croissance plus faible ou le début d'un développement plus horizontal. La valeur est probablement en train de développer une formation de type tête-épaules. Un franchissement établi sous le support à 6988, mieux encore sur un volume en croissance, peut annoncer une poursuite de la baisse. L'indice a marginalement franchi le support à environ 7160 points. Un franchissement établi et persistant peut indiquer une poursuite de la baisse. La courbe RSI montre une tendance baissière, ce qui pourrait être le signal précursuer d'une nouvelle tendance baissière. L'indice est généralement considéré comme neutre technique pour moyen long terme.
S&P 500
   Candidat légèrement positif
S&P 500 fluctue dans un canal haussier, qui indique une poursuite de la croissance. L'indice fluctue entre le support à environ 2930 points et la résistance à environ 3020 points. Un franchissement d'un des deux niveaux peut indiquer la direction de développement à venir. Le RSI diverge négativement par rapport au prix, ce qui indique un danger possible d'une réaction à la baisse. L'indice est généralement considéré comme légèrement positif technique pour moyen long terme.
Cas du jour
GlaxoSmithKline PLC (GSK) Cours 1646.20, 18. oct 2019
GlaxoSmithKline PLC fluctue dans un canal haussier, qui indique une poursuite de la croissance. La valeur fluctue dans une formation rectangulaire entre un support à 1606 et une résistance à 1749. Un franchissement établi d'un des deux niveaux peut donner des indications pour le développement futur. La valeur a pâti un peu, après le débordement d'une formation rectangulaire. Il y a un support à 1645, ce qui, en ce moment, ouvre à des occasions intéressantes d'achat. Cependant, un franchissement établi sous le support peut neutraliser la recommandation d'achat. L'action s'approche du support à environ 1620 pence, ce qui peut indiquer qu'un rebond est possible. L'action est généralement considéré comme positif technique pour moyen long terme.
Recommendation: Positif
Index du jour précédent
AEX-0.62%572.72
ATX0.00%3406.09
CAC40-0.65%5636.25
COMPX-0.83%8089.54
DAX-0.17%12634
HEX0.06%9515.42
N100-0.58%1089.39
OMXC25GI-0.96%1193.16
OMXSPI0.50%636.57
OSEBX-0.06%893.12
PSI20-0.73%4977.16
TECDAX-0.81%2778.43
UKX-0.44%7150.57
EURUSD0.16%111.4932
CL (OIL)-0.28%53.78
Estimations d'index
 CML
AEXneutralposneutral
ATXneutralneutralneutral
CAC40pospospos
COMPXneutralnegneutral
DAXpospospos
HEXnegpospos
N100pospospos
OMXC25GInegneutralneutral
OMXSPIpospospos
OSEBXpospospos
PSI20posnegneutral
TECDAXnegpospos
UKXnegneutralpos
EURUSDnegnegneutral
CL (OIL)posnegneutral

C: Court terme.    M: Moyen terme.    L: Long terme .
Baromètre de bourse
FTSE 100 - Moyen terme
 
      
35% 20% 45%
 33 Candidats positifs intéressants
 19 A surveiller
 42 Candidats négatifs intéressants
Cancel Analysis News
Conditions générales d'utilisation et avis de précaution Copyright © 2019 Investtech.com AS, Org nr 978 655 424 MVA


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

[ Back to default newsletter setup ]

Customised newsletter

Investtech subscribers can customise AnalysisNews. Add your own stocks, your own portfolios, etc, and get the updates directly to your inbox. A customised newsletter is the best way to get a daily overview of the market and your own investments.
Wherever you see this button, you can click it in order to add a simplified version of the page to AnalysisNews or to your start page.

Edit AnalysisNews

Register as a recipient of AnalysisNews in order to customise the content.
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now